UCL’s international agenda is about placing an international dimension at the heart of a unique and outstanding student experience. It is about attracting and supporting a diverse international staff and student community of the highest calibre as well as extending UCL’s network of international partnerships and collaborations in education, research, business and healthcare, and with the global development sector, governments, charities and philanthropists.

The international agenda is also concerned with extending the global reach of UCL’s distinctive mission as well as achieving the widest possible recognition for the university’s approach to internationalisation.

UCL’s global presence can be seen around the world – with two overseas campuses in Australia and Qatar – as well as numerous partnerships with institutions and organisations. Over 11,000 international students from 154 countries study at UCL in London. They are joined by 3,000 international academic and professional services staff who come from 113 countries. Together, this global community works collaboratively to make a difference in the world.

UCL is one of the world’s leading multi-disciplinary universities. It operates in a global context and is committed to excellence, innovation and the promotion of global understanding in all its activities, from research, teaching and learning to enterprise and community engagement.

UCL is London’s global university.


UCL Global News and Case Studies

UCL IOE

UCL and the Institute of Education confirm merger

UCL and the Institute of Education (IOE) have today confirmed that they will be merging with effect from 2 December. The merger will create a new institution with over 35,000 students, confirming UCL as the biggest higher education institution in London, and the largest postgraduate institution in the UK, with 19,000 postgraduate students. It will have over 11,000 staff and a combined income of over £1bn. More...

Mycobacterium tuberculosis

Simplifying TB treatments to improve patients’ lives

Ways to simplify treatments for tuberculosis (TB) to reduce drug resistance and make it easier for patients to complete their course of treatment have been trialled by two international groups involving UCL scientists. More...